Navigation Links
U.S. Appeals Court Reinstates Claim That Controversial Diet Drug Redux Should Never Have Been Offered to American People
Date:8/19/2010

CINCINNATI, Ohio, Aug. 19 /PRNewswire-USNewswire/ -- An Ohio Federal Court of Appeals ruling issued yesterday is reinstating the late victim's claim that the recalled diet drug Redux (commonly called fen-phen) linked to her death should never have been marketed to the American people by Wyeth due in part to its pre-approval concerns about potentially lethal side effects. The Court, in remanding the case to the trial court, held that Federal drug regulations do not preempt Ohio negligence claims, and indicated that the Supreme Court's 2009 landmark pharmaceutical manufacturer preemption decision (Wyeth v. Levine) may apply beyond inadequate warning-label claims.

Benjamin H. Anderson, Esq., of Anderson Law Offices, LLC of Cleveland, Ohio, counsel for the plaintiff, said, "Mary Buchanan, like so many others, turned to a drug to help her lose weight and as a result she lost her life. She and her surviving family members deserve justice; this is an important decision in her case and for the harms and losses she sustained, as well as the many millions of Americans taking prescription medications who have long been concerned about drug companies being shielded from appropriate state negligence laws. Significantly, the appeals court has also reinstated and remanded to the trial court our claim for punitive damages."

In reversing key sections of the trial court's finding for the defendant on summary judgment in Wimbush v. Wyeth et.al., 6th Cir. No. 09-3380, the three-judge appeals panel held that the trial judge erred in concluding that the U.S. Food and Drug Administration (FDA) preempted the Buchanan family's negligence claims that the drug should never have been made available to Americans given Wyeth-Redux's known health risks, particularly Primary Pulmonary Hypertension (PPH). Mrs. Buchanan, a hard-working and dedicated 66- year-old nurse from Maple Heights, Ohio who took the weight-loss drug during 1996 and 1997, lost her life to PPH in 2003 wit
'/>"/>

SOURCE Anderson Law Firm
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. U.S. Court of Appeals Rules on Validity of Lillys Gemzar Method-of-Use Patent
2. Federal Appeals Court Rules Pharmaceutical Sales Reps Entitled to Overtime Pay
3. Watson Says Appeals Court Affirms Concerta(R) Patent Invalid
4. U.S. Court of Appeals Upholds AstraZeneca AWP Settlement
5. German District Court Finds RENASYS™ GO NPWT System Non-infringing
6. Appellate Court Sides With Terminally-Ill Medical Marijuana Patient
7. CRESTOR® Patent Upheld By US Court
8. Appellate Court Decides in Favor of Fenwal
9. Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty
10. Pharma CI Conference Amy Yueh Pays $52,000 to Apaporis LLC to Satisfy Judgment Against Her In Superior Court Of New Jersey Case
11. Montana Supreme Court Decision Endangers Most Vulnerable Citizens
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... 2, 2014   Intrexon Corporation (NYSE: ... announced that it has entered into an Exclusive Channel ... of Sanofi (EURONEXT: SAN and NYSE: SNY ... specific family of its marketed Active Pharmaceutical Ingredients (APIs) ... . This collaboration will leverage Intrexon,s proprietary technology ...
(Date:9/2/2014)... Cepheid (NASDAQ: CPHD) announced today the release ... molecular test for rapid, accurate and reliable determination ... RSV infection. The test will be marketed as ... In Vitro Diagnostic Medical Devices, bringing ... Xpert Flu/RSV XC runs on Cepheid,s GeneXpert ® ...
(Date:9/2/2014)... -- Sinovac Biotech Ltd. (NASDAQ: SVA ), a leading ... today announced that the Company,s management will participate in the ... Global Healthcare Conference, to be held at the Grand Hyatt ... Morgan Stanley Asia Pacific Healthcare Day, to be held at ... Aegis Healthcare & Technology Conference, to be held at the ...
Breaking Medicine Technology:Intrexon Announces Exclusive Channel Collaboration with Sanofi to Optimize Production for a Specific Family of Active Pharmaceutical Ingredients 2Intrexon Announces Exclusive Channel Collaboration with Sanofi to Optimize Production for a Specific Family of Active Pharmaceutical Ingredients 3Cepheid Announces European Release of Xpert Flu/RSV XC for Accurate and Reliable Detection and Differentiation of Flu A, Flu B, and RSV Infection 2Cepheid Announces European Release of Xpert Flu/RSV XC for Accurate and Reliable Detection and Differentiation of Flu A, Flu B, and RSV Infection 3Cepheid Announces European Release of Xpert Flu/RSV XC for Accurate and Reliable Detection and Differentiation of Flu A, Flu B, and RSV Infection 4Sinovac to Participate in Upcoming Investor Conferences 2
... 28, 2011 Burg Simpson Eldredge Hersh & Jardine, P.C., ... delighted to announce that shareholder, Seth. A. Katz, has been ... a member of the Plaintiffs, Steering Committee in the multidistrict litigation ... ASR XL Acetabular Hip System. In August 2010, ...
... 28, 2011 Awarepoint Corporation, a privately held ... with 91 hospital sites contracted consisting of 45,062,013 ... network coverage in U.S. hospitals and 135,265 healthcare ... enterprise-wide U.S. hospital client base for RTLS in ...
Cached Medicine Technology:Burg Simpson Leads National Litigation Against DePuy Orthopaedics, Inc. 2Awarepoint Announces RTLS in Healthcare Leadership with 2010 Results 2Awarepoint Announces RTLS in Healthcare Leadership with 2010 Results 3Awarepoint Announces RTLS in Healthcare Leadership with 2010 Results 4
(Date:9/2/2014)... key to more youthful immune function might already be ... the Journal of Leukocyte Biology ... mice had different responses to Mycobacterium tuberculosis ... reversed by ibuprofen. , "Inflammation in old age can ... Ph.D., a researcher involved in the work from the ...
(Date:9/2/2014)... 02, 2014 According to a ... the leading global authority in medical device market ... is expected to grow to over €2 billion ... increase in the number of procedures for the ... This market includes TURP devices, laser BPH devices, ...
(Date:9/2/2014)... 2014 Nanomedicine is essentially based ... treating and/or prevention of diseases and infections. Nanotechnology-based ... neurological, and oncology diseases. , Nanomedicine is ... various nanoparticles, their medical usages, and their actions ... scope for research in this domain, and scientists ...
(Date:9/2/2014)... September 02, 2014 On Saturday, September 6, ... and fitness fair ¡Vive tu vida! Get Up! Get Moving!®. ... for better health and wellness for people of all ages ... to the public, will be held at Kiest Park Recreation ... to 1:00 pm. , “Since 2007, we have partnered ...
(Date:9/2/2014)... Durable Medical Goods manufacture ThermoTek , announced ... company LeaseQ, Inc. to help customers acquire capital goods ... LeaseQ’s breakthrough finance shopping platform has enabled businesses to ... run their business. , Said LeaseQ Vice President ... sales team to provide customers faster access to capital ...
Breaking Medicine News(10 mins):Health News:European Urological Device Market Is Expected to Grow to over €2 billion by 2020: Led by Coloplast, Wellspect HealthCare, Teleflex, C. R. Bard and Olympus 2Health News:European Urological Device Market Is Expected to Grow to over €2 billion by 2020: Led by Coloplast, Wellspect HealthCare, Teleflex, C. R. Bard and Olympus 3Health News:Nanomedicine Market: An Overview of Growth Factors and Future Prospects by Transparency Market Research 2Health News:Nanomedicine Market: An Overview of Growth Factors and Future Prospects by Transparency Market Research 3Health News:The Concilio Presents Eighth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 2Health News:The Concilio Presents Eighth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 3Health News:The Concilio Presents Eighth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 4Health News:Medical Technology Manufacturer ThermoTek Announces New Partnership with LeaseQ.com to Help More Customers Acquire Equipment Faster and Cheaper 2
... have found out the benefits of oral ZYVOX for ... bacterial infections. They compared data from 80 health care ... of Intravenous Vancomycin. The results show that oral tablets ... of money spent to health clinics compared to vancomycin. ...
... from Children’s Hospital of Boston have reconstructed defective ... researchers used amniotic fluid for growing the sections ... living tissues into lambs, while they were in ... used for altering birth defects. Undifferentiated stem cell ...
... a life of dignity with access to medicines and care ... cancer, say experts on the eve of World Hospice and ... states like Kerala, Maharashtra, Karnataka and Orissa as well as ... administer strong pain killers that make life more bearable., ...
... is calling for concerted action following the recent release ... (WHO). // ,"Preventing Chronic Diseases: A ... global burden of chronic diseases including cardiovascular disease, cancer, ... global action to prevent chronic disease could save the ...
... total abdominal hysterectomy and laparoscopically assisted vaginal hysterectomy ... the advantages of lower morbidity // and faster ... vaginal route, although there is a high feasibility ... gynecologists need to be familiar with surgical techniques. ...
... and obstructive sleep apnea share some common symptoms, due to ... diagnosis. Obstructive sleep apnea (OSA) occurs when the tongue or ... the airway. This can happen more than 50 times an ... last as long as 60 seconds. The problem is twice ...
Cached Medicine News:Health News:Oral use of ZYVOX (Linezolid) is better to Intravenous Vancomycin use for Skin Infections 2Health News:Terminally Ill deserves a better quality of Life 2Health News:Terminally Ill deserves a better quality of Life 3Health News:Reversibility of symptoms of depression using CPAP in patients with obstructive sleep apnea 2
Used for implantation to reinforce soft tissue in the repair of a hernia or body wall defect. Supplied sterile in peel-open packages. Intended for one-time use....
... is a new, portable, light weight, high ... dermatology, cosmetic and plastic surgery, general surgery, ... skin resurfacing, it is the smallest, yet ... the market. It provides an ideal treatment ...
... Surgical Laser System is designed for ... high-power, dual-wavelength system designed for urology, ... surgery, neurosurgery, pulmonary surgery and gastroenterology ... vaporizes and coagulates tissue with minimal ...
... biolitecs sophisticated Ceralas D15/810 diode laser is ... ideal for many soft tissue applications. With ... D15/810 features a flexible fiber optic delivery ... irrigated or dry environments alike.,Compact and portable, ...
Medicine Products: